Stemgent
Latest round
- Series C
Last raised
- Feb 2012
Total raised
- $38M
Investors
- 2
About Stemgent
Based in Massachusetts, US, and founded in 2007, Stemgent Inc. operates as a biotechnology firm that offers tools and resources for stem cell research. The company was founded by Ian Ratcliffe. Stemgent provides tools for stem cell research, with a particular emphasis on cellular reprogramming, a technique for converting adult cells into induced pluripotent stem cells (iPSCs). The firm offers a range of tools specifically designed for generating iPSCs, including cell lines, small molecules, and antibodies. The firm offers human iPSC-derived cells, collagen products, small molecules, and perfusion plates. In addition, the firm offers training courses focused on cellular reprogramming.
Who invested in Stemgent
2 investors across 5 rounds
See all investors in Stemgent
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Stemgent
Who invested in Stemgent?
Stemgent has 2 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Stemgent raised?
Stemgent has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Stemgent last raise money?
Stemgent's most recent round on record is a Series C, in Feb 2012.
What does Stemgent do?
Based in Massachusetts, US, and founded in 2007, Stemgent Inc.
Where is Stemgent headquartered?
Stemgent is headquartered in Lexington, US.
Which VCs invest in companies like Stemgent?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Stemgent's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Stemgent? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.